SCHEMBL6233644

SCHEMBL6233644

CCCNc1ccccc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.47
IDO1 P14902 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
ICMT O60725 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 2/20 0.41
LMNA P02545 1/20 0.41
ALDH1A1 P00352 1/20 0.40
TRPA1 O75762 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27489390 0.88 SMN1; SMN2 (0.58) PSIP1SMN1; SMN2L3MBTL1CYP1A2CYP3A4
SCHEMBL29563275 0.86 SMN1; SMN2 (0.53) PSIP1SMN1; SMN2L3MBTL1MAPTHTT
SCHEMBL6232014 0.86 SMN1; SMN2 (0.53) PSIP1SMN1; SMN2L3MBTL1MAPTHTT
SCHEMBL11512622 0.84 IDO1 (0.55) IDO1MAPTHTT
SCHEMBL479327 0.82 PSIP1 (0.53) PSIP1SMN1; SMN2L3MBTL1IDO1TAS1R3
SCHEMBL12656153 0.82 PSIP1 (0.46) PSIP1SMN1; SMN2L3MBTL1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL3323107 0.80 PSIP1 (0.52) PSIP1SMN1; SMN2L3MBTL1IDO1TAS1R3
SCHEMBL26416944 0.80 CA12 (0.57) PSIP1SMN1; SMN2L3MBTL1IDO1MAPT
SCHEMBL10798671 0.79 CHEK1 (0.54) PSIP1SMN1; SMN2L3MBTL1IDO1CYP1A2
SCHEMBL18434515 0.79 L3MBTL1 (0.45) PSIP1SMN1; SMN2L3MBTL1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9656956-B2 Benzene, pyridine, and pyridazine derivatives ESANEX, INC. (US) 2017-05-23 US disclosed
WO-2012075232-A1 OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING THE SAME TREVENA, INC. (US) 2012-06-07 WO disclosed
EP-1530562-A1 OPTICALLY ACTIVE 1-(FLUORO-,TRIFLUOROMETHYL-OR TRIFLUOROMETHOXY-SUBSTITUTED PHENYL)ALKYLAMINE N-MONOALKYL DERIVATIVES AND PROCESS FOR PRODUCING SAME Central Glass Company, Limited (JP) 2005-05-18 EP disclosed
WO-2004022521-A1 OPTICALLY ACTIVE 1-(FLUORO-,TRIFLUOROMETHYL-OR TRIFLUOROMETHOXY-SUBSTITUTED PHENYL)ALKYLAMINE N-MONOALKYL DERIVATIVES AND PROCESS FOR PRODUCING SAME CENTRAL GLASS COMPANY, LIMITED (JP) 2004-03-18 WO disclosed
EP-1377555-A1 NOVEL COMPOUNDS GlaxoSmithKline S.p.A. (IT) 2004-01-07 EP disclosed
WO-2002083645-A1 NOVEL COMPOUNDS GLAXOSMITHKLINE S.P.A. (IT) 2002-10-24 WO disclosed
EP-0711289-B1 PIPERAZINE COMPOUNDS USED IN THERAPY DELTA PHARMACEUTICALS INC (US) 2000-08-23 EP disclosed
US-5681830-A DIARYLMETHYL PIPERAZINE COMPOUNDS HAVING UTILITY IN MEDICAL THERAPY AS RECEPTOR-BINDING SPECIES DELTA PHARMACEUTICALS, INC. (US) 1997-10-28 US disclosed
US-5574159-A DIARYLMETHYL PIPERAZINES, RECEPTOR BINDING DELTA PHARMACEUTICALS, INC. (US) 1996-11-12 US disclosed
US-5552404-A COMPOUNDS FOR NEUROTRANSMITTERS FOR ANIMALS DELTA PHARMACEUTICALS, INC. (US) 1996-09-03 US disclosed
EP-0711289-A1 PIPERAZINE COMPOUNDS USED IN THERAPY DELTA PHARMACEUTICALS, INC. (US) 1996-05-15 EP disclosed
WO-1995004051-A1 PIPERAZINE COMPOUNDS USED IN THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1995-02-09 WO disclosed